A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax

NCT02572635 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: PnuBioVax
BIOLOGICAL: Placebo

Sponsor

ImmunoBiology Limited

Collaborators

[object Object]
[object Object]
[object Object]